ClinicalTrials.gg
Sign In

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) clinical trials

Listed in the registry as: U.S. National Institutes of Health.

The registry lists 537 studies whose lead sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). 54 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2026.

Keep track of what changes. Save the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Status

Completed
424
Recruiting
46
Terminated
26
Withdrawn
15
Active, not recruiting
10
Not yet recruiting
8

Phase

Phase 2
157
Phase 3
71
Phase 1
41
Phase 4
15
Early Phase 1
4

Where

United States
506
Canada
33
Australia
8
Italy
6
United Kingdom
5
Finland
3

Focus areas

Conditions National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Diabetes Mellitus82Obesity58Diabetes Mellitus, Type 250Diabetes Mellitus, Type 141Hepatitis39Kidney Diseases30Hepatitis C25Insulin Resistance23Liver Diseases23Non-alcoholic Fatty Liver Disease19Overweight18Hepatitis C, Chronic17Fatty Liver16Hepatitis B15Lipodystrophy13Cardiovascular Diseases12Cystic Fibrosis11Kidney Failure, Chronic11Liver Cirrhosis11Weight Gain11Glomerulosclerosis, Focal Segmental10Hepatitis B, Chronic10Hypertension10

Studies

Recruiting first, then most recently updated. Showing 50 of 537. Browse all 537 →